CLINICAL BENEFIT OF LENALIDOMIDE TREATMENT FOR LOW AND INTERMEDIATE-1 IPSS RISK MYELODYSPLASTIC SYNDROME WITH DEL(5Q) BEFORE TRANSFUSION DEPENDENCE

被引：0
|
作者：
Oliva, E. [1 ]
Lauseker, M. [2 ]
Spiriti, M. A. Aloe [3 ]
Poloni, A. [4 ]
Cortelezzi, A. [5 ]
Palumbo, G. [6 ]
Balleari, E. [7 ]
Sanpaolo, G. [8 ]
Volpe, A. [9 ]
Ricco, A. [10 ]
Ronco, F. [1 ]
Alati, C. [1 ]
Santacaterina, I. [1 ]
Kuendgen, A. [11 ]
Germing, U. [11 ]
Latagliata, R. [12 ]
机构：
[1] Azienda Osped BMM, Reggio Di Calabria, Italy
[2] Univ Munich, Inst Med Informat Sci Biometry & Epidemiol, Munich, Germany
[3] Univ Roma La Sapienza, Dipartimento Med Clin & Mol, I-00185 Rome, Italy
[4] Univ Politecn Marche, Ancona, Italy
[5] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
[6] Azienda Osped Univ Policlin Vittorio Emanuele, Catania, Italy
[7] Osped San Martino Genova, Hematol Unit, Genoa, Italy
[8] Osped Casa Sollievo della Sofferenza, Hematol Div, San Giovanni Rotondo, Italy
[9] Azienda Osped San G Moscati, Avellino, Italy
[10] Univ Bari, Bari, Italy
[11] Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, Dusseldorf, Germany
[12] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S1331
引用
收藏
页码：517 / 517
页数：1
相关论文
共 50 条
  • [31] Lenalidomide for anemia correction in lower-risk del(5q) myelodysplastic syndrome patients of Asian ethnicity
    Hong, Junshik
    Lee, Yoo Jin
    Bae, Sung Hwa
    Yi, Jun Ho
    Park, Sungwoo
    Chang, Myung Hee
    Park, Young Hoon
    Hyun, Shin Young
    Chung, Joo-Seop
    Jang, Ji Eun
    Jung, Joo Young
    Jeon, So-Yeon
    Song, Seo-Young
    Kim, Hawk
    Kim, Dae Sik
    Kim, Sung-Hyun
    Kim, Min Kyoung
    Han, Sang Hoon
    Park, Seonyang
    Kim, Yoo-Jin
    Lee, Je-Hwan
    BLOOD RESEARCH, 2021, 56 (02) : 102 - 107
  • [32] A RANDOMISED STUDY OF LENALIDOMIDE (LEN) plus /- EPO IN RBC TRANSFUSION DEPENDENT (TD) IPSS LOW AND INT-1 (LOWER RISK) MYELODYSPLASTIC SYNDROMES (MDS) WITHOUT DEL 5Q RESISTANT TO EPO
    Toma, A.
    Chevret, S.
    Kosmider, O.
    Delaunay, J.
    Stamatoullas, A.
    Rose, C.
    Beyne-Rauzy, O.
    Banos, A.
    Guerci-Bresler, A.
    Jourdan, E.
    Sardnal, V.
    Caillot, D.
    Laribi, K.
    de Renzis, B.
    Bordessoule, D.
    Slama, B.
    Sanhes, L.
    Fontenay, M.
    Fenaux, P.
    Dreyfus, F.
    HAEMATOLOGICA, 2013, 98 : 454 - 455
  • [33] ELTROMBOPAG FOR THE TREATMENT OF THROMBOCYTOPENIA OF LOW AND INTERMEDIATE-1 IPSS RISK MYELODYSPLASTIC SYNDROMES: RESULTS OF A PROSPECTIVE, RANDOMIZED, TRIAL
    Oliva, E.
    Santini, V.
    Zini, G.
    Palumbo, G.
    Poloni, A.
    Cortelezzi, A.
    Rodeghiero, F.
    Voso, M.
    Molteni, A.
    Sanpaolo, G.
    Liberati, A.
    Morabito, F.
    Balleari, E.
    Impera, S.
    Salvi, F.
    Spiriti, M.
    Marino, A.
    Roda, F.
    Alati, C.
    Ronco, F.
    Raimondo, F.
    Leoni, P.
    Alimena, G.
    Fioritoni, G.
    Latagliata, R.
    Nobile, F.
    HAEMATOLOGICA, 2013, 98 : 456 - 456
  • [34] Improved survival rates with continued treatment with hypomethylating agents in patients with myelodysplastic syndrome in IPSS low and intermediate-1
    Moon, J.
    Sohn, S. K.
    Kim, Y. K.
    Kim, H. J.
    Lim, S. N.
    Kim, M. K.
    Do, Y. R.
    Song, M. K.
    Lee, W. S.
    Lee, S. M.
    Kim, H.
    Won, J. H.
    Jo, D. Y.
    LEUKEMIA RESEARCH, 2013, 37 : S165 - S166
  • [35] Eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: Results of a prospective, randomized trial
    Oliva, E. N.
    Santini, V.
    Zini, G.
    Palumbo, G. A.
    Poloni, A.
    Cortelezzi, A.
    Rodeghiero, F.
    Voso, M. T.
    Molteni, A.
    Sanpaolo, G.
    Liberati, M.
    Morabito, F.
    Balleari, E.
    Impera, S.
    Salvi, F.
    Spiriti, M. A. Aloe
    Marino, A.
    Roda, F.
    Alati, C.
    Ronco, F.
    Di Raimondo, F.
    Leoni, P.
    Alimena, G.
    Latagliata, R.
    Nobile, F.
    LEUKEMIA RESEARCH, 2013, 37 : S162 - S162
  • [36] Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide
    Merkerova, Michaela Dostalova
    Krejcik, Zdenek
    Belickova, Monika
    Hrustincova, Andrea
    Klema, Jiri
    Stara, Eliska
    Zemanova, Zuzana
    Michalova, Kyra
    Cermak, Jaroslav
    Jonasova, Anna
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 95 (01) : 35 - 43
  • [37] Aberrant expression of the microRNA cluster in 14q32 is associated with del(5q) myelodysplastic syndrome and lenalidomide treatment
    Krejcik, Zdenek
    Belickova, Monika
    Hrustincova, Andrea
    Klema, Jiri
    Zemanova, Zuzana
    Michalova, Kyra
    Cermak, Jaroslav
    Jonasova, Anna
    Merkerova, Michaela Dostalova
    CANCER GENETICS, 2015, 208 (04) : 156 - 161
  • [38] Comparison of the Molecular Spectrum of Lenalidomide-Treated Myelodysplastic Syndrome with and without Del(5q)
    Adema, Vera
    Palomo, Laura
    Fuster-Tormo, Francisco
    Benito, Rocio
    Salgado, Rocio
    Such, Esperanza
    Kosmider, Olivier
    Larrayoz, Maria Jose
    Xicoy, Blanca
    Janusz, Kamila
    Maietta, Paolo
    Neef, Alexander
    Amunchastegui, Beatriz Arrizabalaga
    Fontenay, Michaela
    Gomez-Marzo, Paula
    Del Rey, Monica
    Ibanez, Mariam
    Haro, Nuri
    Mallo, Mar
    Zamora, Lurdes
    Visconte, Valeria
    Maciejewski, Jaroslaw P.
    Fenaux, Pierre
    Cervera, Jose
    Calasanz, Maria Jose
    Hernandez-Rivas, Jesus Maria
    Cigudosa, Juan
    Sole, Francesc
    BLOOD, 2016, 128 (22)
  • [39] Azacitidine Treatment of Lenalidomide-Resistant Myelodysplastic Syndrome with Deletion 5q
    Komrokji, Rami S.
    Al Ali, Najla H.
    Padron, Eric
    Lancet, Jeffrey E.
    List, Alan F.
    BLOOD, 2011, 118 (21) : 1195 - 1195
  • [40] Cytogenetic Evolution in Patients with IPSS Low and Intermediate-1 Risk. Study from the Spanish Group of Myelodysplastic Syndrome
    Marcel Merchan, Brayan
    Ortega, Margarita
    Jose Llamas-Poyato, Mara
    Cortes, Montserrat
    Arnan, Montserrat
    Cervero, Carlos
    Montoro, Julia
    Gimenez, Teresa
    Lopez, Mara
    Arenillas, Leonor
    Valcarcel, David
    BLOOD, 2014, 124 (21)
12345